Predictions
Hugo Boss AG NA
Start price
Target price
Perf. (%)
€53.38
21.09.22
21.09.22
-
21.12.22
21.12.22
-11.75%
29.09.22
29.09.22
Business model of the past or high risk
Below average Marketposition
Little known brand
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€146.94
21.09.22
21.09.22
€120.00
21.09.23
21.09.23
-24.49%
19.12.22
19.12.22
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
Immunocore Holdings Plc
Start price
Target price
Perf. (%)
€44.20
20.09.22
20.09.22
€70.00
31.12.25
31.12.25
22.17%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Sfc Energy AG
Start price
Target price
Perf. (%)
€20.50
20.09.22
20.09.22
€16.00
20.09.23
20.09.23
-13.46%
01.10.22
01.10.22
Small challenges to pay loans and raise capital
Capable Management
Revenue growth >5% per year expected
EBIT growth >5% per year expected
flatexDEGIRO AG
Start price
Target price
Perf. (%)
€9.18
20.09.22
20.09.22
€6.00
20.09.23
20.09.23
0.33%
01.10.22
01.10.22
Could be worthwhile Investment >10% per year
Good culture
Below average Management
Little innovation
Ringmetall SE
Start price
Target price
Perf. (%)
€4.87
20.09.22
20.09.22
€6.00
20.09.23
20.09.23
-12.73%
01.10.22
01.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Altech Advanced Materials AG
Start price
Target price
Perf. (%)
€6.20
20.09.22
20.09.22
€4.00
20.09.23
20.09.23
-15.48%
01.10.22
01.10.22
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Significant cyclical dependencies
Little known brand
Carbios S.A.
Start price
Target price
Perf. (%)
€25.90
20.09.22
20.09.22
€18.60
20.09.23
20.09.23
-9.81%
13.10.22
13.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Alibaba Health Information Technology Ltd
Start price
Target price
Perf. (%)
€0.51
20.09.22
20.09.22
€0.40
20.09.23
20.09.23
-10.61%
03.10.22
03.10.22
Revenue growth >5% per year expected
Low dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
20.09.22
20.09.22
€1.80
20.09.23
20.09.23
36.59%
19.11.22
19.11.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Inovio Pharma
Start price
Target price
Perf. (%)
€1.88
20.09.22
20.09.22
€1.60
20.09.23
20.09.23
-7.46%
03.10.22
03.10.22
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€7.75
20.09.22
20.09.22
€3.00
20.09.23
20.09.23
-52.24%
11.01.23
11.01.23
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Very low/no dividend yield expected
very negative Cash Flow expected
Mercadolibre Inc
Start price
Target price
Perf. (%)
€910.20
20.09.22
20.09.22
€830.00
20.09.23
20.09.23
-6.83%
03.10.22
03.10.22
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
International Business Machines Corp
Start price
Target price
Perf. (%)
€125.86
20.09.22
20.09.22
€131.00
20.09.23
20.09.23
10.39%
31.10.22
31.10.22
Could be worthwhile Investment >10% per year
High dividend yield expected
Standard Investments for future growth
Future proof or reliable business model
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€1.17
20.09.22
20.09.22
-
20.09.23
20.09.23
-15.38%
15.10.22
15.10.22
Risky Investment
Top Dividenden Aristokraten (WF)
Start price
Target price
Perf. (%)
€164.91
20.09.22
20.09.22
€175.00
20.09.23
20.09.23
2.04%
21.09.23
21.09.23
Visa Inc. A
Start price
Target price
Perf. (%)
€193.40
20.09.22
20.09.22
€239.00
20.09.23
20.09.23
17.24%
21.09.23
21.09.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Well known brand
Danone S.A.
Start price
Target price
Perf. (%)
€49.80
20.09.22
20.09.22
€65.00
20.09.23
20.09.23
7.37%
21.09.23
21.09.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€16.65
20.09.22
20.09.22
€32.00
31.01.23
31.01.23
-17.72%
30.09.22
30.09.22
Could be very worthwhile Investment >20% year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.18
20.09.22
20.09.22
€7.00
31.08.25
31.08.25
32.08%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Coeur Mining Inc.
Start price
Target price
Perf. (%)
€3.35
19.09.22
19.09.22
-
19.09.23
19.09.23
9.28%
07.10.22
07.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group